What the FDA Approval of Nemolizumab Means for Prurigo Nodularis, with Gil Yosipovitch, MD
HCPLive
AUGUST 17, 2024
In this interview, Yosipovitch discusses his team’s findings on nemolizumab and the significance of the drug’s FDA approval for those with prurigo nodularis.
Let's personalize your content